about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More
1.70
0.16
(10.39%)
2.4M
XNAS Volume
XNAS 05 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Cabaletta Bio Inc is on 10 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..